Benefits of capecitabine in hormone receptor-positive compared to hormone receptor-negative HER2 normal metastatic breast cancer

Med Oncol. 2024 May 10;41(6):146. doi: 10.1007/s12032-024-02389-3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antimetabolites, Antineoplastic* / therapeutic use
  • Breast Neoplasms* / drug therapy
  • Breast Neoplasms* / metabolism
  • Breast Neoplasms* / pathology
  • Capecitabine* / administration & dosage
  • Capecitabine* / therapeutic use
  • Female
  • Humans
  • Middle Aged
  • Receptor, ErbB-2* / metabolism
  • Receptors, Estrogen* / metabolism
  • Receptors, Progesterone* / metabolism

Substances

  • Capecitabine
  • Receptor, ErbB-2
  • ERBB2 protein, human
  • Receptors, Estrogen
  • Antimetabolites, Antineoplastic
  • Receptors, Progesterone